SCN10A Gene Episodic Pain Syndrome Type 2 Familial Genetic Test
Are you experiencing recurrent episodes of severe pain in your limbs, face, and/or torso? It could be a result of episodic pain syndrome type 2, a rare genetic disorder associated with the SCN10A gene. At DNA Labs UAE, we offer a comprehensive genetic test to diagnose this condition and provide appropriate treatment options.
Test Details
The SCN10A gene is responsible for episodic pain syndrome type 2, a rare genetic disorder characterized by recurrent episodes of severe pain. This disorder is inherited in an autosomal dominant pattern, meaning that if you have the mutation, there is a 50% chance of passing it on to your children. Our NGS genetic testing for SCN10A can identify mutations in this gene that are associated with episodic pain syndrome type 2. This testing involves sequencing the entire SCN10A gene to detect any genetic changes that may be causing the disorder.
Components and Price
Our SCN10A Gene Episodic Pain Syndrome Type 2 Familial Genetic Test is priced at 4400.0 AED. We accept blood samples, extracted DNA, or one drop of blood on an FTA card as sample conditions.
Report Delivery and Method
You can expect to receive your test results within 3 to 4 weeks. We utilize NGS technology for our genetic testing, ensuring accurate and reliable results.
Test Type and Doctor
This test falls under the category of Neurological Disorders and is conducted by our experienced Neurologists in our Genetics department.
Pre Test Information
Prior to undergoing the SCN10A Gene Episodic Pain Syndrome Type 2 Familial Genetic Test, we recommend providing your clinical history. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of your family members affected by SCN10A Gene Episodic Pain Syndrome Type 2, familial.
Is Genetic Testing Necessary?
It is important to note that genetic testing is not always necessary or appropriate for every individual with episodic pain syndrome type 2. Our doctors may recommend testing based on your symptoms, family history, and other factors. Genetic counseling is also recommended to help you understand the implications of your test results and make informed decisions about your healthcare.
Don’t let episodic pain syndrome type 2 hold you back. Contact DNA Labs UAE today to schedule your SCN10A Gene Episodic Pain Syndrome Type 2 Familial Genetic Test and take control of your health.
Test Name | SCN10A Gene Episodic pain syndrome type 2 familial Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SCN10A Gene Episodic pain syndrome type 2, familial NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN10A Gene Episodic pain syndrome type 2, familial |
Test Details |
The SCN10A gene is associated with episodic pain syndrome type 2, which is a rare genetic disorder characterized by recurrent episodes of severe pain in the limbs, face, and/or torso. This disorder is inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing on the mutation to each of their children. NGS genetic testing for SCN10A can identify mutations in this gene that are associated with episodic pain syndrome type 2. This testing involves sequencing the entire SCN10A gene to detect any genetic changes that may be causing the disorder. This information can help doctors diagnose the condition and provide appropriate treatment and management options. It is important to note that genetic testing is not always necessary or appropriate for every individual with episodic pain syndrome type 2. A doctor may recommend testing based on a patient’s symptoms, family history, and other factors. Genetic counseling is also recommended for individuals who are considering genetic testing, as it can help them understand the implications of their test results and make informed decisions about their healthcare. |